Seeing Is Believing
Tetraphase Pharmaceuticals's activity chart (see below) currently has 49 price targets and 44 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50.9% with an average time for these price targets to be met of 84.23 days.
Most recent stock forecast was given by KEVIN KEDRA from GABELLI on 07-May-2020. First documented stock forecast 05-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
6 years 5 months 15 days ago
(07-May-2020)
1/2 (50%)
$36.05 (72.09%)
304
Hold Since 03-Sep-2019
$140
7 years 1 months 19 days ago
(03-Sep-2019)
0/3 (0%)
$69.6 (98.86%)
Buy Since 19-Nov-2015
$4
$1.8 (81.82%)
7 years 5 months 13 days ago
(09-May-2019)
1/2 (50%)
$-16 (-80.00%)
151
Buy Since 11-Sep-2017
$4
$1.8 (81.82%)
7 years 7 months 7 days ago
(15-Mar-2019)
1/3 (33.33%)
$-24.2 (-85.82%)
206
$140
$137.8 (6263.64%)
$120
8 years 1 months 24 days ago
(28-Aug-2018)
0/3 (0%)
$69.6 (98.86%)
What is TTPH (Tetraphase Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on TTPH (Tetraphase Pharmaceuticals)?
Which analyst has the most public recommendations on TTPH (Tetraphase Pharmaceuticals)?
Which analyst is the currently most bullish on TTPH (Tetraphase Pharmaceuticals)?
Which analyst is the currently most reserved on TTPH (Tetraphase Pharmaceuticals)?